These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 11073979

  • 1. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
    Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC.
    Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
    [Abstract] [Full Text] [Related]

  • 2. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T.
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [Abstract] [Full Text] [Related]

  • 3. Intimate relationship between TGF-beta/BMP signaling and runt domain transcription factor, PEBP2/CBF.
    Bae SC, Lee KS, Zhang YW, Ito Y.
    J Bone Joint Surg Am; 2001 Aug; 83-A Suppl 1(Pt 1):S48-55. PubMed ID: 11263665
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chihara K.
    J Biol Chem; 2004 Sep 24; 279(39):40267-75. PubMed ID: 15150273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K, Zhang L, Jin T, Rutherford RB.
    Cells Tissues Organs; 2004 Sep 24; 176(1-3):28-40. PubMed ID: 14745233
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation.
    Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Galléa S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G.
    Bone; 2001 Oct 24; 29(4):323-30. PubMed ID: 11595614
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation.
    Ying SX, Hussain ZJ, Zhang YE.
    J Biol Chem; 2003 Oct 03; 278(40):39029-36. PubMed ID: 12871975
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R.
    Nat Med; 2003 Jul 03; 9(7):964-8. PubMed ID: 12808448
    [Abstract] [Full Text] [Related]

  • 20. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway.
    Haÿ E, Lemonnier J, Fromigué O, Marie PJ.
    J Biol Chem; 2001 Aug 03; 276(31):29028-36. PubMed ID: 11395480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.